Altered hypothalamic-pituitary-adrenal axis activity in patients with chronic heart failure

Hormone and Metabolic Research

Volumn 41, Issue 10, 2009, Pages 778-784

  Sivukhina, E V ^a   Poskrebysheva, A S ^b   Smurova, Iu V ^b   Dolzhikov, A A ^c   Morozov, Iu E ^d   Jirikowski, G F ^a   Grinevich, V ^e  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^c Regional Clinical Hospital   (Russian Federation)

^d Regional Medical Expert Bureau of Medical Legal Examination   (Russian Federation)

^e MAX PLANCK INSTITUTE FOR MEDICAL RESEARCH   (Germany)

Author keywords

ACTH; Corticotrophin releasing; Cortisol; Hormone; HPA axis; Vasopressin

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; NEUROHORMONE; VASOPRESSIN;

ADRENAL CORTEX; ADULT; AGED; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; DYSTROPHY; FEMALE; HEART FAILURE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; NERVE CELL; PARALLEL DESIGN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THALAMUS MIDLINE NUCLEUS; UPREGULATION; ZONA FASCICULATA;

ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; AGED, 80 AND OVER; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HEART FAILURE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; VASOPRESSINS;

EID: 70350359080     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0029-1224182     Document Type: Article

References (38)

1. Sato Y, Miyamoto T, Taniguchi R, Nishio Y, Kita T, Fujiwara H, Takatsu Y. Current understanding of biochemical markers in heart failure. Med Sci Moni 2006 12 RA252-RA264
2. Packer M. How should physicians view heart failure?. The philosophical and physiological evolution of three conceptual models of disease. Am J Cardiol 1993 71 3C-11C
3. Francis GS. Pathophysiology of chronic heart failure. Am J Med 2001 110 (Suppl 7A) 37S-46S
4. Roig Minguell E. Clinical use of markers of neurohormonal activation in heart failure. Rev Esp Cardiol 2004 57 347-356
5. Scott LV, Dinan TG. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression. Life Sci 1998 62 1985-1998
6. Grinevich V, Ma X-M, Herman J, Jezova D, Akmayev I, Aguilera G. Effect of repeated lipopolysaccharide administration on tissue cytokine expression and hypothalamic-pituitary-adrenal axis activity in rats. J Neuroendocrinol 2001 13 711-723
7. Lightman SL, Windle RJ, Ma XM, Harbuz MS, Shanks NM, Julian MD, Wood SA, Kershaw YM, Ingram CD. Hypothalamic-pituitary-adrenal function. Arch Physiol Biochem 2002 110 90-93
8. Aguilera G. Regulation of pituitary ACTH secretion during chronic stress. Front Neuroendocrinol 1994 15 321-350
9. Bito K, Kubo S, Saimyoji H. Role of endocrine factors in chronic congestive heart failure, with emphasis on catecholamines. Jpn Circ J 1980 44 117-127
10. Moriyama Y, Yasue H, Yoshimura M, Mizuno Y, Nishiyama K, Tsunoda R, Kawano H, Kugiyama K, Ogawa H, Saito Y, Nakao K. The plasma levels of dehydroepiandrosterone sulfate are decreased in patients with chronic heart failure in proportion to the severity. J Clin Endocrinol Metab 2000 85 1834-1840
11. Lobzeva VI, Rylova AK, Zhemerikina EV, Novikov FE. Adaptive reserves of the myocardium in patients with ischemic heart disease. Kardiologiia 1990 30 22-24
12. Lu L, Li WM. Clinical significance of the function of adrenal cortex in refractory congestive heart failure. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2003 15 489-491
13. Gallina S, Prosperino G, Di Giovanni P, Gaeta F, Di Napoli P, Gaeta MA, Muzii G, Barsotti A. The prognostic value of activation of the hypophyseal and adrenal cortical systems in severe heart failure. Cardiologia 1997 42 77-82
14. Emdin M, Passino C, Prontera C, Iervasi A, Ripoli A, Masini S, Zucchelli GC, Clerico A. Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure. Clin Chem Lab Med 2004 42 627-636
15. Güder G, Bauersachs J, Frantz S, Weismann D, Allolio B, Ertl G, Angermann CE, Störk S. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure. Circulation 2007 115 1754-1761
16. Van Cauter E, Leproult R, Kupfer DJ. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 1996 81 2468-2473
17. Kasatkina LV, Pivovarov VN, Markova EV, Salem S, Rossel's AN. Blood hormones in chronic ischemic heart disease and acute myocardial infarct. Kardiologiia 1979 19 93-98
18. Kang YM, Zhang ZH, Johnson RF, Yu Y, Beltz T, Johnson AK, Weiss RM, Felder RB. Novel effect of mineralocorticoid receptor antagonism to reduce proinflammatory cytokines and hypothalamic activation in rats with ischemia-induced heart failure. Circ Res 2006 99 758-766
19. Kang YM, Zhang ZH, Xue B, Weiss RM, Felder RB. Inhibition of brain proinflammatory cytokine synthesis reduces hypothalamic excitation in rats with ischemia-induced heart failure. Am J Physiol Heart Circ Physiol 2008 295 H227-H236
20. Sivukhina EV, Dolzhikov AA, Morozov IuE, Jirikowski GF, Grinevich V. Effects of chronic alcoholic disease on magnocellular and parvocellular hypothalamic neurons in men. Horm Metab Res 2006 38 382-390
21. Ben-Barak Y, Russel JT, Whitnal MH, Ozato K, Gainer H. Neurophysin in the hypothalamo-neurohypophyseal system. I. Production and characterization of monoclonal antibodies. J Neurosci 1985 5 81-97
22. Whitnall MH, Key S, Ben-Barak Y, Ozato K, Gainer H. Neurophysin in the hypothalamo-neurohypophyseal system. II. Immunohistochemical studies of the ontogeny of oxytocinergic and vasopressinergic neurons. J Neurosci 1985 5 98-109
23. Goncharuk VD, Van Heerikhuize J, Swaab DF, Buijs RM. Paraventricular nucleus of the human hypothalamus in primary hypertension: activation of corticotropin-releasing hormone neurons. J Comp Neurol 2002 443 321-331
24. Irintchev A, Rollenhagen A, Troncoso E, Kiss JZ, Schachner M. Structural and functional aberrations in the cerebral cortex of tenascin-C deficient mice. Cereb Cortex 2005 15 950-962
25. Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF. Increased numbers of corticotrophin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 1994 60 436-444
26. Purba JS, Raadsheer FC, Hofman MA, Ravid R, Polman CH, Kamphorst W, Swaab DF. Increased number of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of patients with multiple sclerosis. Neuroendocrinology. 1995 62 62-70
27. Goncharuk VD, Buijs RM, Swaab DF. Corticotropin-releasing hormone neurons in hypertensive patients are activated in the hypothalamus but not in the brainstem. J Comp Neurol 2007 503 148-168
28. Lynd-Balta E, Pilcher WH, Joseph SA. Adrenocorticotropic hormone immunoreactivity in the hippocampal formation of temporal lobe epilepsy patients. Epilepsia 1996 37 1081-1087 (Pubitemid 26391239)
29. Patel KP, Zhang PL, Krukoff TL. Alterations in brain hexokinase activity associated with heart failure in rats. Am J Physiol 1993 265 R923-R928
30. Zhang ZH, Francis J, Weiss RW, Felder RB. The renin-angiotensin- aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure. Am J Physiol Heart Circ Physiol 2002 283 H423-H433
31. Aguilera G, Pham Q, Rabadan-Diehl C. Regulation of pituitary vasopressin receptors during chronic stress: relationship to corticotroph responsiveness. J Neuroendocrinol 1994 6 299-304
32. Wand GS, Dobs AS. Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics. J Clin Endocrinol Metab 1991 72 1290-1295
33. Zych-Twardowska E, Wajgt A. Blood levels of selected hormones in patients with multiple sclerosis. Med Sci Monit 2001 7 1005-1012
34. Swaab DF, Raadsheer FC, Endert E, Hofman MA, Kamphorst W, Ravid R. Increased cortisol levels in aging and Alzheimer's disease in postmortem cerebrospinal fluid. J Neuroendocrinol 1994 6 681-687
35. Raadsheer FC, Oorschot DE, Verwer RW, Tilders FJ, Swaab DF. Age-related increase in the total number of corticotropin-releasing hormone neurons in the human paraventricular nucleus in controls and Alzheimer's disease: comparison of the disector with an unfolding method. J Comp Neurol 1994 339 447-457
36. Dickstein G, Shechner C, Nicholson WE, Rosner I, Shen-Orr Z, Adawi F, Lahav M. Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab 1991 72 773-778
37. Silva TS, Longui CA, Faria CD, Rocha MN, Melo MR, Faria TG, de Souzae, Almeida JA, Hayashi LF, Kater CE. Impact of prolonged physical training on the pituitary glucocorticoid sensitivity determined by very low dose intravenous dexamethasone suppression test. Horm Metab Res 2008 40 718-721
38. Torpy DJ, Ho JT. Value of free cortisol measurement in systemic infection. Horm Metab Res 2007 39 439-444